GCM2 and cancer: In our study, we used a set of 96 tumor samples of less than 2 cm; in this set, the assessment of the methylation of the GCM2, ITPRIPL1, CACNA1E, and DLGAP2 genes most accurately distinguished cancer from healthy tissues.